Related Experiment Video
Updated: Jun 21, 2026
06:58
Global Identification of Co-Translational Interaction Networks by Selective Ribosome Profiling
Published on: October 7, 2021
Cost effective analysis of ribosome-component immune modulation
Alessandro Fiocchi1, Dario Olivieri, Sergio Marcassa
1Department of Child and Maternal Medicine, Melloni Hospital, Milan, Italy.
Allergy and Asthma Proceedings
|August 15, 2009
Summary
Ribosomal immunotherapy can significantly reduce healthcare costs associated with recurrent respiratory infections in children. This immune modulator offers economic benefits by decreasing treatment expenses and improving productivity.
Area of Science:
- Pediatrics
- Immunology
- Health Economics
Background:
- Recurrent airway infections are a leading cause of pediatric medical visits and hospitalizations, incurring substantial healthcare costs.
- The use of ribosomal bacterial vaccines and membrane fractions is often limited to prevention, despite proven efficacy and safety for treatment.
- Economic impact of recurrent respiratory infections includes direct medical costs and indirect productivity losses.
Purpose of the Study:
- To analyze the economic benefits of using ribosomal immunotherapy for recurrent respiratory infections.
- To evaluate the cost-effectiveness of immune modulators derived from bacterial components.
Main Methods:
- A literature review of pharmacoeconomic studies was conducted.
- Analysis focused on economic parameters related to the use of ribosome component immune modulators.
- Included direct and indirect cost considerations for recurrent respiratory infections.
Main Results:
- Ribosomal immunotherapy demonstrates the capability to reduce expenditures for recurrent respiratory infection treatment.
- Significant savings are achievable in terms of direct costs, time, and productivity loss.
- The initial investment in prevention through immunotherapy is offset by long-term savings due to reduced disease recurrence.
Conclusions:
- Ribosomal immunotherapy offers a cost-effective strategy for managing recurrent respiratory infections in children.
- Integrating the costs of treatment and productivity losses highlights the economic advantages of this therapeutic approach.
- Primary care physicians should consider both direct and indirect costs when evaluating treatment options for chronic respiratory infections.
Related Concept Videos
02:24Ribosome Profiling
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...